Hansa Biopharma Reports Third Quarter and Interim January – September 2024 Financial Results

Posted on by

Q3 2024 marks highest ever in-market quarterly sales performance and fourth consecutive quarter of strong sales performance LUND, Sweden, Oct. 17, 2024 /PRNewswire/ — Hansa Biopharma today announced its interim report for January-September and third quarter 2024 financial results. Søren…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.